Earnings, virus news to dictate direction of stock prices
US stocks rose slightly last week as a vaccine breakthrough boosted hopes that the world could return to normal.
The gains could moderate this week if earnings reports are as dire as anticipated and Covid-19 outbreaks in the US sun belt become deadlier.
Shares of Moderna surged after the biotech company, which has never succeeded in bringing a drug to market, said that its experimental, RNA-based vaccine showed impressive levels of efficacy in a mid-stage clinical trial.
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Companies & Markets
TikTok tells advertisers: ‘We are not backing down’
EV automakers get reprieve in US tax credit rules
Nomura, Mizuho face losses on All Blue fund’s failed trades
Stablecoin Tether steps up monitoring in bid to combat illicit finance
HSBC asked by US$890 billion investor group to set energy goal
BHP’s biggest rivals sit on the sidelines of Anglo M&A drama